Skip to content

Measuring Vestibular Organ Function With Weak Alternating Current Stimulation

Measuring Vestibular Organ Function With Weak Alternating-current Stimulation

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07267910
Acronym
VESTI
Enrollment
30
Registered
2025-12-05
Start date
2026-06-08
Completion date
2027-12-01
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Disorder, Vestibular Neuritis, Vestibular Schwannoma

Keywords

Vestibular disorders, Otorhinolaryngologic Diseases, Electrical vestibular stimulation, transcranial electrical stimulation

Brief summary

The goal of this clinical trial is to preliminarily evaluate the use of electrical stimulation in diagnosing disorders with the vestibular system. The main questions it aims to answer are: * Can electrical vestibular stimulation combined with movement measurement be used to diagnose disorders of the vestibular system? * Can electrical stimulation provide treatment or rehabilitation opportunities for patients suffering from disorders of the vestibular system?

Detailed description

The participants will each attend one experimental session consisting of multiple short (1-3 min) measurement trials. During a trial the participant's vestibular system is stimulated with a transcranial electrical stimulator device and their movements are recorded with a force plate and acceleration sensors. The goal of the study is to collect and analyse data from 30 research participants with diagnosed vestibular disorders.

Interventions

DEVICEActive transcranial electrical vestibular stimulation (Active EVS)

Active transcranial electrical vestibular stimulation (EVS) with alternating current (maximum peak current below 2 mA and stimulation frequency 2-20 Hz) applied for 1-3 minutes at a time and for under 20 minutes in total. EVS will be applied either bilaterally (ear to ear) or unilaterally (left ear to neck or right ear to neck). The participants movements during the stimulation are measured with a force plate and wearable acceleration sensors. The study uses multiple types of vestibular stimulation waveforms which are applied in a randomized sequence, such that neither the participant nor the investigator know the exact stimulation type at the time of the measurement.

DEVICESham transcranial electrical vestibular stimulation (Sham EVS)

Sham (no current) transcranial electrical vestibular stimulation applied for 1-3 minutes. The participant's movements during the supposed stimulation are measured with a force plate and wearable acceleration sensors. Neither the participant nor the investigator know at what point of the intervention sequence the sham stimulation is applied.

DEVICEControl measurement

The participant's movements are measured with a force plate and wearable acceleration sensors for the same time duration (1-3 min) and following the same protocols as in other interventions, but both the participant and the investigator know that no stimulation is being applied. The control measurement will always be completed before all other interventions and is not part of the randomized intervention sequence.

Sponsors

Aalto University
Lead SponsorOTHER
Helsinki University Central Hospital
CollaboratorOTHER
Business Finland
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

All study participants will get the same interventions but in different randomized order. The investigator does know the possible types of intervention but not the order they will be applied in. Therefore at the time of applying the intervention neither the participant nor the investigator know which specific intervention is being applied.

Intervention model description

All study participants will get the same interventions but in different randomized order. The order randomization is based on the balanced Latin square design such that each intervention type occurs equally often in each position in the order, so that any order effects are distributed evenly among the subjects.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent form * One of the following: clinically diagnosed vestibular schwannoma, vestibular neuritis, or simultaneous unilateral hearing loss and vestibular dysfunction.

Exclusion criteria

* History of epilepsy or seizures * Past brain surgery * Pacemaker, cochlear implant, or other implanted medical device * Pregnancy * Skin problems or damaged skin at the site of the stimulation (scalp and neck)

Design outcomes

Primary

MeasureTime frameDescription
Changes in the frequency content of the movement response signalsFrom study appointment to the analysis of the results (up to 12 months)Changes of the power in a frequency band of 0-20 Hz in the measured movement response signals during active electrical vestibular stimulation (EVS). The measured movement response signals are force plate Center of Pressure (CoP) and 3-axis acceleration data from wearable acceleration sensors.

Secondary

MeasureTime frameDescription
Latency of the EVS responseFrom study appointment to the analysis of the results (up to 12 months)Latency of the EVS-induced movement response measured as the time delay between the stimulation and the measured movement.
Highest frequency of the EVS-induced responseFrom study appointment to the analysis of the results (up to 12 months)Highest frequency at which EVS induces a response determined via spectral analysis of the movement data

Countries

Finland

Contacts

PRINCIPAL_INVESTIGATORIlkka Laakso, D.Sc. (Tech)

Aalto University

PRINCIPAL_INVESTIGATORTopi Jutila, MD, PhD

HUS Helsinki University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026